Normalized periprostatic fat MRI measurements can predict prostate cancer aggressiveness in men undergoing radical prostatectomy for clinically localised disease

Abstract Periprostatic and pelvic fat have been shown to influence prostate cancer behaviour through the secretion of chemokines and growth factors, acting in a paracrine mode. We have measured periprostatic fat volume (PFV) with normalisation to prostate gland volume on pelvic magnetic resonance im...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Naief Dahran, Magdalena Szewczyk-Bieda, Cheng Wei, Sarah Vinnicombe, Ghulam Nabi
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/1fc6e14cd68a477182343e822a53d794
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1fc6e14cd68a477182343e822a53d794
record_format dspace
spelling oai:doaj.org-article:1fc6e14cd68a477182343e822a53d7942021-12-02T11:52:56ZNormalized periprostatic fat MRI measurements can predict prostate cancer aggressiveness in men undergoing radical prostatectomy for clinically localised disease10.1038/s41598-017-04951-82045-2322https://doaj.org/article/1fc6e14cd68a477182343e822a53d7942017-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-04951-8https://doaj.org/toc/2045-2322Abstract Periprostatic and pelvic fat have been shown to influence prostate cancer behaviour through the secretion of chemokines and growth factors, acting in a paracrine mode. We have measured periprostatic fat volume (PFV) with normalisation to prostate gland volume on pelvic magnetic resonance imaging (MRI) and have correlated this with grade (Gleason score; GS) and pathological staging (pT) of prostate cancer (PCa) following radical prostatectomy (RP). PFV was determined using a segmentation technique on contiguous T1-weighted axial MRI slices from the level of the prostate base to the apex. The abdominal fat area (AFA) and subcutaneous fat thickness (SFT) were measured using T1-weighted axial slices at the level of the umbilicus and the upper border of the symphysis pubis, respectively. PFV was normalised to prostate volume (PV) to account for variations in PV (NPFV = PFV/PV). Patients were stratified into three risk groups according to post-operative GS: ≤6, 7(3 + 4), and ≥7(4 + 3). NPFV was significantly different between the groups (p = 0.001) and positively correlated with post-operative GS (ρ = 0.294, p < 0.001). There was a difference in NPFV between those with upgrading of GS from 6 post prostatectomy (2.43 ± 0.98; n = 26) compared to those who continued to be low grade (1.99 ± 0.82; n = 17); however, this did not reach statistical significance (p = 0.11).Naief DahranMagdalena Szewczyk-BiedaCheng WeiSarah VinnicombeGhulam NabiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Naief Dahran
Magdalena Szewczyk-Bieda
Cheng Wei
Sarah Vinnicombe
Ghulam Nabi
Normalized periprostatic fat MRI measurements can predict prostate cancer aggressiveness in men undergoing radical prostatectomy for clinically localised disease
description Abstract Periprostatic and pelvic fat have been shown to influence prostate cancer behaviour through the secretion of chemokines and growth factors, acting in a paracrine mode. We have measured periprostatic fat volume (PFV) with normalisation to prostate gland volume on pelvic magnetic resonance imaging (MRI) and have correlated this with grade (Gleason score; GS) and pathological staging (pT) of prostate cancer (PCa) following radical prostatectomy (RP). PFV was determined using a segmentation technique on contiguous T1-weighted axial MRI slices from the level of the prostate base to the apex. The abdominal fat area (AFA) and subcutaneous fat thickness (SFT) were measured using T1-weighted axial slices at the level of the umbilicus and the upper border of the symphysis pubis, respectively. PFV was normalised to prostate volume (PV) to account for variations in PV (NPFV = PFV/PV). Patients were stratified into three risk groups according to post-operative GS: ≤6, 7(3 + 4), and ≥7(4 + 3). NPFV was significantly different between the groups (p = 0.001) and positively correlated with post-operative GS (ρ = 0.294, p < 0.001). There was a difference in NPFV between those with upgrading of GS from 6 post prostatectomy (2.43 ± 0.98; n = 26) compared to those who continued to be low grade (1.99 ± 0.82; n = 17); however, this did not reach statistical significance (p = 0.11).
format article
author Naief Dahran
Magdalena Szewczyk-Bieda
Cheng Wei
Sarah Vinnicombe
Ghulam Nabi
author_facet Naief Dahran
Magdalena Szewczyk-Bieda
Cheng Wei
Sarah Vinnicombe
Ghulam Nabi
author_sort Naief Dahran
title Normalized periprostatic fat MRI measurements can predict prostate cancer aggressiveness in men undergoing radical prostatectomy for clinically localised disease
title_short Normalized periprostatic fat MRI measurements can predict prostate cancer aggressiveness in men undergoing radical prostatectomy for clinically localised disease
title_full Normalized periprostatic fat MRI measurements can predict prostate cancer aggressiveness in men undergoing radical prostatectomy for clinically localised disease
title_fullStr Normalized periprostatic fat MRI measurements can predict prostate cancer aggressiveness in men undergoing radical prostatectomy for clinically localised disease
title_full_unstemmed Normalized periprostatic fat MRI measurements can predict prostate cancer aggressiveness in men undergoing radical prostatectomy for clinically localised disease
title_sort normalized periprostatic fat mri measurements can predict prostate cancer aggressiveness in men undergoing radical prostatectomy for clinically localised disease
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/1fc6e14cd68a477182343e822a53d794
work_keys_str_mv AT naiefdahran normalizedperiprostaticfatmrimeasurementscanpredictprostatecanceraggressivenessinmenundergoingradicalprostatectomyforclinicallylocaliseddisease
AT magdalenaszewczykbieda normalizedperiprostaticfatmrimeasurementscanpredictprostatecanceraggressivenessinmenundergoingradicalprostatectomyforclinicallylocaliseddisease
AT chengwei normalizedperiprostaticfatmrimeasurementscanpredictprostatecanceraggressivenessinmenundergoingradicalprostatectomyforclinicallylocaliseddisease
AT sarahvinnicombe normalizedperiprostaticfatmrimeasurementscanpredictprostatecanceraggressivenessinmenundergoingradicalprostatectomyforclinicallylocaliseddisease
AT ghulamnabi normalizedperiprostaticfatmrimeasurementscanpredictprostatecanceraggressivenessinmenundergoingradicalprostatectomyforclinicallylocaliseddisease
_version_ 1718394911956402176